NASDAQ:AZN

AstraZeneca Earning Date

USA |NASDAQ |USD |ADR

AZN Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 5, 2021 (est) Sep 30, 2021 - $0.45 $0.47
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 5, 2021 (est) Sep 30, 2021 - $8.22B $6.58B

Astrazeneca's next estimated earnings date (based on same quarter last year's date) is Nov 5, 2021 for the fiscal quarter ending Sep 30, 2021.

AZN Earnings Date & History Chart

AZN Earnings & Revenue Forecast

AZN Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 2 $0.73 $0.69 $0.77
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $3.27 $2.57 $5.15
Dec 2022 4 $3.98 $3.00 $5.80

AZN Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $0.77 $0.77 $0.73
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 1 $3.52 $2.70 $3.33
Dec 2022 0 / 1 $4.41 $3.71 $4.18

AZN Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 3 $10.77B $10.37B $11.09B
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $36.18B $35.51B $36.73B
Dec 2022 4 $42.93B $42.24B $43.70B

AZN Earnings Date & Revenue History

AZN Earnings History

|
Show More
Show More

AZN Revenue History

|
Show More
Show More

Astrazeneca Next Earnings Date & Report

AZN Jul 2021 (FQ) Earnings Date & Report Preview

AZN's next estimated earnings date (based on same quarter last year's report date) is Nov 5, 2021 for the fiscal quarter ending Sep 30, 2021.

Astrazeneca Previous Earnings Dates & Reports

AZN Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Astrazeneca's previous earnings date was Jul 29, 2021 for its fiscal quarter ended Jun 30, 2021.

AZN's earnings per share (EPS) was $0.45, missing the consensus analysts forecast of $0.69 by -34.38%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by -44.79%, and lower than the same period a year before (Jun 2020) by -6.25%.

Revenues were $8.22B, better than the forecast of $7.59B by 8.36%, up by 12.30% from the previous quarter , and up by 31.00% from the same period last year.

The company reported a net income of $550.00M, -64.77% lower than the previous quarter, and lower by -27.25% than the same period a year before.

Free cash flow for the quarter was $539.00M , compared to $1.47B last quarter and $63.00M a year before.

AZN ended the quarter with $27.50B in total debt, an increase of 36.57% compared to the previous quarter, and an increase of 42.59% compared to the same quarter a year before.

AZN Previous Earnings Date & Report Recap: Dec 2020 (FY)

Astrazeneca's previous annual earnings date was Feb 11, 2021 for its fiscal year ended Dec 31, 2020.

AZN's earnings per share (EPS) was $2.02, missing the consensus analysts forecast of $2.47 by -18.42% , and higher than the previous year's EPS (Dec 2019) by 15.14%.

Revenues were $26.62B, better than the forecast of $26.24B by 1.42%, and up by 9.16% from previous year's revenue.

The company reported a net income of $3.20B, 139.40% higher than the previous year.

Astrazeneca reported a free cash flow of $2.19B for its fiscal year, compared to $509.00M a year ago.

The company ended the fiscal year with $19.89B in total debt, an increase of 12.13% compared to the previous year.